Table 1 Patient characteristics
TTFields | P-value | ||
|---|---|---|---|
CA-TTF (N = 41) | A-TTF (N = 31) | ||
Sex | |||
Female | 13 (31.7%) | 13 (41.9%) | 0.518 |
Male | 28 (68.3%) | 18 (58.1%) | |
Age (years) | |||
Median [Min, Max] | 53.0 [22.0, 76.0] | 48.0 [19.0, 74.0] | 0.615 |
Extent of resection | |||
GTR | 28 (68.3%) | 23 (74.2%) | 0.777 |
STR/Biopsy | 13 (31.7%) | 8 (25.8%) | |
MGMT promoter methylation | |||
Methylated | 15 (36.6%) | 10 (32.3%) | 0.907 |
Unmethylated | 24 (58.5%) | 19 (61.3%) | |
Unknown | 2 (4.9%) | 2 (6.5%) | |
TERT promoter mutation status | |||
Wild-type | 12 (29.3%) | 14 (45.2%) | 0.192 |
Mutation | 26 (63.4%) | 13 (41.9%) | |
Unknown | 3 (7.3%) | 4 (12.9%) | |
Baseline KPS | |||
Median [Min, Max] | 90.0 [60.0, 90.0] | 80.0 [60.0, 90.0] | 0.443 |
Compliance with TTFields (hours/day) | |||
Median [Min, Max] | 21.1 [8.88, 23.0] | 21.6 [15.8, 23.3] | 0.491 |
Duration of TTFields (months) | |||
Median [Min, Max] | 10.0 [1.00, 31.0] | 10.4 [1.00, 35.0] | 0.203 |